{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:20:26Z","timestamp":1791883226148,"version":"4.3.4"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007246","name":"Y\u00fcksek\u00f6\u011fretim Kurulu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008770","name":"Anadolu University","doi-asserted-by":"publisher","award":["2102S003"],"award-info":[{"award-number":["2102S003"]}],"id":[{"id":"10.13039\/501100008770","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.abb.2024.110099","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T08:58:05Z","timestamp":1720947485000},"page":"110099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Dynamics of small molecule-enzyme interactions: Novel benzenesulfonamides as multi-target agents endowed with inhibitory effects against some metabolic enzymes"],"prefix":"10.1016","volume":"759","author":[{"given":"\u00d6zcan","family":"G\u00fcle\u00e7","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2932-2789","authenticated-orcid":false,"given":"C\u00fcneyt","family":"T\u00fcrke\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0796-4374","authenticated-orcid":false,"given":"Mustafa","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesut","family":"I\u015f\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeliz","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice Esra","family":"Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammet","family":"F\u0131rat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6mer \u0130rfan","family":"K\u00fcfrevio\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015e\u00fckr\u00fc","family":"Beydemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.abb.2024.110099_bib1","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2174\/138955712802762356","article-title":"CNS drug development-lost in translation?","volume":"12","author":"Talevi","year":"2012","journal-title":"Mini-Rev. Med. Chem."},{"issue":"2","key":"10.1016\/j.abb.2024.110099_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/ph7020113","article-title":"From single target to multitarget\/network therapeutics in Alzheimer's therapy","volume":"7","author":"Zheng","year":"2014","journal-title":"Pharmaceuticals"},{"issue":"18","key":"10.1016\/j.abb.2024.110099_bib3","doi-asserted-by":"crossref","first-page":"12651","DOI":"10.1021\/acs.jmedchem.2c01737","article-title":"Is target-based drug discovery efficient? Discovery and \u201coff-target\u201d mechanisms of all drugs","volume":"66","author":"Sadri","year":"2023","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.abb.2024.110099_bib4","first-page":"1","article-title":"Gene\u2013environment interactions and their impact on human health","volume":"24","author":"Virolainen","year":"2023","journal-title":"Gene Immun."},{"issue":"8","key":"10.1016\/j.abb.2024.110099_bib5","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.3390\/molecules25081987","article-title":"Type 2 diabetes mellitus: a review of multi-target drugs","volume":"25","author":"Artasensi","year":"2020","journal-title":"Molecules"},{"issue":"13","key":"10.1016\/j.abb.2024.110099_bib6","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1021\/acs.jmedchem.0c00733","article-title":"Sulfonamide inhibitors of human carbonic anhydrases designed through a three-tails approach: improving ligand\/isoform matching and selectivity of action","volume":"63","author":"Bonardi","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.abb.2024.110099_bib7","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.cej.2019.01.079","article-title":"The influence of bromide on the degradation of sulfonamides in UV\/free chlorine treatment: degradation mechanism, DBPs formation and toxicity assessment","volume":"362","author":"Xiang","year":"2019","journal-title":"Chem. Eng. J. (Lausanne)"},{"issue":"2","key":"10.1016\/j.abb.2024.110099_bib8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1021\/acsmedchemlett.5b00272","article-title":"Novel oxindole sulfonamides and sulfamides: EPZ031686, the first orally bioavailable small molecule SMYD3 inhibitor","volume":"7","author":"Mitchell","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.abb.2024.110099_bib9","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1134\/S1070428022060136","article-title":"Blue light-induced coupling of N-hydroxy sulfonamides: an efficient and green approach to symmetrical thiosulfonates","volume":"58","author":"Pandey","year":"2022","journal-title":"Russ. J. Org. Chem."},{"issue":"7","key":"10.1016\/j.abb.2024.110099_bib10","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/ange.201309162","article-title":"Ligand bite angle\u2010dependent palladium\u2010catalyzed cyclization of propargylic carbonates to 2\u2010alkynyl azacycles or cyclic dienamides","volume":"126","author":"Daniels","year":"2014","journal-title":"Angew. Chem."},{"issue":"19","key":"10.1016\/j.abb.2024.110099_bib11","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.2174\/1389557520666200905125738","article-title":"From antibacterial to antitumour agents: a brief review on the chemical and medicinal aspects of sulfonamides","volume":"20","author":"Azevedo-Barbosa","year":"2020","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.abb.2024.110099_bib12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.bioorg.2018.11.033","article-title":"Synthesis and anti-inflammatory activity of sulfonamides and carboxylates incorporating trimellitimides: dual cyclooxygenase\/carbonic anhydrase inhibitory actions","volume":"84","author":"Alaa","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.abb.2024.110099_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/molecules28010051","article-title":"Sulfonamides with heterocyclic periphery as antiviral agents","volume":"28","author":"Moskalik","year":"2022","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.abb.2024.110099_bib14","doi-asserted-by":"crossref","first-page":"7664","DOI":"10.1039\/D4RA01060D","article-title":"Novel sulfonamide derivatives as multitarget antidiabetic agents: design, synthesis, and biological evaluation","volume":"14","author":"Ayoup","year":"2024","journal-title":"RSC Adv."},{"issue":"3","key":"10.1016\/j.abb.2024.110099_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"6","key":"10.1016\/j.abb.2024.110099_bib16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2174\/1389557518666181015152433","article-title":"A review exploring therapeutic worth of 1, 3, 4-oxadiazole tailored compounds","volume":"19","author":"Verma","year":"2019","journal-title":"Mini-Rev. Med. Chem."},{"issue":"4","key":"10.1016\/j.abb.2024.110099_bib17","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2174\/1570180814666170512122832","article-title":"Synthesis and anti-influenza activity of novel thiadiazole, oxadiazole and triazole based scaffolds","volume":"15","author":"Tawfik","year":"2018","journal-title":"Lett. Drug Des. Discovery"},{"issue":"11","key":"10.1016\/j.abb.2024.110099_bib18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/ph13110390","article-title":"Synthesis of new 1, 3, 4-oxadiazole-incorporated 1, 2, 3-triazole moieties as potential anticancer agents targeting thymidylate synthase and their docking studies","volume":"13","author":"Alam","year":"2020","journal-title":"Pharmaceuticals"},{"issue":"13","key":"10.1016\/j.abb.2024.110099_bib19","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.3390\/ijms22136979","article-title":"Antimicrobial activity of 1, 3, 4-oxadiazole derivatives","volume":"22","author":"Glomb","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.abb.2024.110099_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejmech.2019.02.055","article-title":"Comprehensive review on the anti-bacterial activity of 1, 2, 3-triazole hybrids","volume":"168","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"15","key":"10.1016\/j.abb.2024.110099_bib21","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1016\/j.bmc.2015.06.053","article-title":"Imidazole clubbed 1, 3, 4-oxadiazole derivatives as potential antifungal agents","volume":"23","author":"Wani","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.abb.2024.110099_bib22","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.bmcl.2008.12.026","article-title":"Synthesis and antifungal activity of 1, 2, 3-triazole containing fluconazole analogues","volume":"19","author":"Aher","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.abb.2024.110099_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bioorg.2016.09.005","article-title":"Novel 1, 3, 4-oxadiazole\/oxime hybrids: synthesis, docking studies and investigation of anti-inflammatory, ulcerogenic liability and analgesic activities","volume":"69","author":"Abd-Ellah","year":"2016","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.abb.2024.110099_bib24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/s40064-016-2052-5","article-title":"Synthesis, anti-inflammatory, bactericidal activities and docking studies of novel 1,2,3-triazoles derived from ibuprofen using click chemistry","volume":"5","author":"Angajala","year":"2016","journal-title":"SpringerPlus"},{"key":"10.1016\/j.abb.2024.110099_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105808","article-title":"Design and synthesis of novel 1, 3, 4-oxadiazole and 1, 2, 4-triazole derivatives as cyclooxygenase-2 inhibitors with anti-inflammatory and antioxidant activity in LPS-stimulated RAW264. 7 macrophages","volume":"124","author":"Hamoud","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.abb.2024.110099_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100158","article-title":"1, 2, 3\u2010Triazole hybrids as anticancer agents: a review","volume":"355","author":"Alam","year":"2022","journal-title":"Arch. Pharm. (Weinheim, Ger.)"},{"issue":"37","key":"10.1016\/j.abb.2024.110099_bib27","doi-asserted-by":"crossref","first-page":"11085","DOI":"10.1021\/acs.jafc.1c03755","article-title":"Antibacterial and antiviral activities of 1,3,4-oxadiazole thioether 4H-Chromen-4-one derivatives","volume":"69","author":"Peng","year":"2021","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.abb.2024.110099_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000163","article-title":"1, 2, 3\u2010Triazole hybrids with anti\u2010HIV\u20101 activity","volume":"354","author":"Feng","year":"2021","journal-title":"Arch. Pharm. (Weinheim, Ger.)"},{"issue":"1","key":"10.1016\/j.abb.2024.110099_bib29","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/jhet.3409","article-title":"Synthesis and biological evaluation of new ibuprofen\u20101, 3, 4\u2010oxadiazole\u20101, 2, 3\u2010triazole hybrids","volume":"56","author":"Rayam","year":"2019","journal-title":"J. Heterocycl. Chem."},{"issue":"6","key":"10.1016\/j.abb.2024.110099_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200009","article-title":"New 1, 3, 4\u2010oxadiazoles linked with the 1, 2, 3\u2010triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase","volume":"355","author":"Mahmoud","year":"2022","journal-title":"Arch. Pharm. (Weinheim, Ger.)"},{"key":"10.1016\/j.abb.2024.110099_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114526","article-title":"Discovery of 1, 3, 4-oxadiazole derivatives containing a bisamide moiety as a novel class of potential cardioprotective agents","volume":"239","author":"Yang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.abb.2024.110099_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112672","article-title":"Synthesis of 1, 3, 4-oxadiazole derivatives with anticonvulsant activity and their binding to the GABAA receptor","volume":"206","author":"Wang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.abb.2024.110099_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000164","article-title":"New N\u2010phenylacetamide\u2010linked 1, 2, 3\u2010triazole\u2010tethered coumarin conjugates: synthesis, bioevaluation, and molecular docking study","volume":"353","author":"Akolkar","year":"2020","journal-title":"Arch. Pharm. (Weinheim, Ger.)"},{"issue":"9","key":"10.1016\/j.abb.2024.110099_bib34","doi-asserted-by":"crossref","first-page":"10192","DOI":"10.3390\/molecules170910192","article-title":"Synthetic approaches and pharmacological activity of 1, 3, 4-oxadiazoles: a review of the literature from 2000\u20132012","volume":"17","author":"De Oliveira","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.abb.2024.110099_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106404","article-title":"Phthalazone tethered 1, 2, 3-triazole conjugates: in silico molecular docking studies, synthesis, in vitro antiproliferative, and kinase inhibitory activities","volume":"133","author":"Abdelgawad","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.abb.2024.110099_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112219","article-title":"Tail approach synthesis of novel benzenesulfonamides incorporating 1, 3, 4-oxadiazole hybrids as potent inhibitor of carbonic anhydrase I, II, IX, and XII isoenzymes","volume":"193","author":"Sharma","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.abb.2024.110099_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105046","article-title":"Synthesis of novel 5-(2, 5-bis (2, 2, 2-trifluoroethoxy) phenyl)-1, 3, 4-oxadiazole-2-thiol derivatives as potential glucosidase inhibitors","volume":"114","author":"Gani","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.abb.2024.110099_bib38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bioorg.2018.08.008","article-title":"Synthesis of 1H-1, 2, 3-triazole derivatives as new \u03b1-glucosidase inhibitors and their molecular docking studies","volume":"81","author":"Avula","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.abb.2024.110099_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2019.127085","article-title":"Synthesis, crystal structures, computational studies and \u03b1-amylase inhibition of three novel 1, 3, 4-oxadiazole derivatives","volume":"1200","author":"Hamdani","year":"2020","journal-title":"J. Mol. Struct."},{"issue":"11","key":"10.1016\/j.abb.2024.110099_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115467","article-title":"Syntheses, in vitro \u03b1-amylase and \u03b1-glucosidase dual inhibitory activities of 4-amino-1, 2, 4-triazole derivatives their molecular docking and kinetic studies","volume":"28","author":"Yeye","year":"2020","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.abb.2024.110099_bib41","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/07391102.2020.1818623","article-title":"Phthalocyanine complexes with (4-isopropylbenzyl) oxy substituents: preparation and evaluation of anti-carbonic anhydrase, anticholinesterase enzymes and molecular docking studies","volume":"40","author":"G\u00fczel","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"8","key":"10.1016\/j.abb.2024.110099_bib42","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1016\/j.bmc.2009.01.067","article-title":"Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols","volume":"17","author":"\u015eent\u00fcrk","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.abb.2024.110099_bib43","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ijbiomac.2016.10.096","article-title":"Novel eugenol derivatives: potent acetylcholinesterase and carbonic anhydrase inhibitors","volume":"94","author":"Topal","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.abb.2024.110099_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103544","article-title":"Benzimidazole derivatives as potent and isoform selective tumor-associated carbonic anhydrase IX\/XII inhibitors","volume":"95","author":"Uslu","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"16","key":"10.1016\/j.abb.2024.110099_bib45","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1080\/00958972.2017.1366996","article-title":"Synthesis, crystal structure, spectroscopy, thermal properties and carbonic anhydrase activities of new metal (II) complexes with mefenamic acid and picoline derivatives","volume":"70","author":"Dilek","year":"2017","journal-title":"J. Coord. Chem."},{"issue":"4","key":"10.1016\/j.abb.2024.110099_bib46","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/cbdd.12561","article-title":"Some anti\u2010inflammatory agents inhibit esterase activities of human carbonic anhydrase isoforms I and II: an in vitro study","volume":"86","author":"Al\u0131m","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"issue":"9","key":"10.1016\/j.abb.2024.110099_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22194","article-title":"1H\u2010indazole molecules reduced the activity of human erythrocytes carbonic anhydrase I and II isoenzymes","volume":"32","author":"Alim","year":"2018","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"7","key":"10.1016\/j.abb.2024.110099_bib48","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/13543776.2018.1487400","article-title":"Sulfonamide inhibitors: a patent review 2013-present","volume":"28","author":"Gul\u00e7in","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.abb.2024.110099_bib49","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/bs.mie.2020.01.003","article-title":"Neutron crystallographic studies of carbonic anhydrase","author":"Combs","year":"2020","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.abb.2024.110099_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103096","article-title":"The green synthesis and molecular docking of novel N-substituted rhodanines as effective inhibitors for carbonic anhydrase and acetylcholinesterase enzymes","volume":"90","author":"Bayindir","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.abb.2024.110099_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129411","article-title":"A simple yet multifaceted 90 years old, evergreen enzyme: carbonic anhydrase, its inhibition and activation","author":"Supuran","year":"2023","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.abb.2024.110099_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103647","article-title":"Cholinesterases, \u03b1-glycosidase, and carbonic anhydrase inhibition properties of 1H-pyrazolo [1, 2-b] phthalazine-5, 10-dione derivatives: synthetic analogues for the treatment of Alzheimer's disease and diabetes mellitus","volume":"97","author":"Taslimi","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.abb.2024.110099_bib53","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bioorg.2018.01.022","article-title":"Synthesis and biological evaluation of novel N, N\u2032-diaryl cyanoguanidines acting as potent and selective carbonic anhydrase II inhibitors","volume":"77","author":"Akocak","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.abb.2024.110099_bib54","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.bioorg.2018.02.015","article-title":"Design and synthesis of novel 1, 3-diaryltriazene-substituted sulfonamides as potent and selective carbonic anhydrase II inhibitors","volume":"77","author":"Lolak","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.abb.2024.110099_bib55","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/14756366.2021.1882453","article-title":"Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase","volume":"36","author":"Nocentini","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.abb.2024.110099_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111638","article-title":"Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: synthesis and biological evaluation","volume":"182","author":"Moi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.abb.2024.110099_bib57","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1021\/acs.jmedchem.3c00007","article-title":"Atropo\/tropo flexibility: a tool for design and synthesis of self-adaptable inhibitors of carbonic anhydrases and their antiproliferative effect","volume":"66","author":"Ivanova","year":"2023","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.abb.2024.110099_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200658","article-title":"Inhibition studies on carbonic anhydrase isoforms I, II, IX, and XII with a series of sulfaguanidines","volume":"18","author":"Abdoli","year":"2023","journal-title":"ChemMedChem"},{"issue":"16","key":"10.1016\/j.abb.2024.110099_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612676","article-title":"Diabetes mellitus secondary to endocrine diseases: an update of diagnostic and treatment particularities","volume":"24","author":"Popoviciu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.abb.2024.110099_bib60","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1007\/s00394-017-1516-x","article-title":"Erythritol reduces small intestinal glucose absorption, increases muscle glucose uptake, improves glucose metabolic enzymes activities and increases expression of Glut-4 and IRS-1 in type 2 diabetic rats","volume":"57","author":"Chukwuma","year":"2018","journal-title":"Eur. J. Nutr."},{"issue":"3","key":"10.1016\/j.abb.2024.110099_bib61","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/bioengineering9030105","article-title":"Extracellular vesicles in type 1 diabetes: a versatile tool","volume":"9","author":"Suire","year":"2022","journal-title":"Bioengineering"},{"issue":"23","key":"10.1016\/j.abb.2024.110099_bib62","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.2174\/0929867328999201123194510","article-title":"The role of plant-derived compounds in managing diabetes mellitus: a review of literature from 2014 to 2019","volume":"28","author":"El-Nashar","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.abb.2024.110099_bib63","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s11030-022-10527-0","article-title":"Novel bis-ureido-substituted sulfaguanidines and sulfisoxazoles as carbonic anhydrase and acetylcholinesterase inhibitors","volume":"27","author":"Lolak","year":"2023","journal-title":"Mol. Divers."},{"issue":"18","key":"10.1016\/j.abb.2024.110099_bib64","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/S0021-9258(18)95800-X","article-title":"Esterase activities of human carbonic anhydrases B and C","volume":"242","author":"Verpoorte","year":"1967","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.abb.2024.110099_bib65","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/bmc.2761","article-title":"Rapid screening and identification of \u03b1-glucosidase inhibitors from mulberry leaves using enzyme-immobilized magnetic beads coupled with HPLC\/MS and NMR","volume":"27","author":"Tao","year":"2013","journal-title":"Biomed. Chromatogr."},{"issue":"1","key":"10.1016\/j.abb.2024.110099_bib66","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ab.2006.01.036","article-title":"A quantitative starch? Iodine method for measuring alpha-amylase and glucoamylase activities","volume":"351","author":"Xiao","year":"2006","journal-title":"Anal. Biochem."},{"issue":"3","key":"10.1016\/j.abb.2024.110099_bib67","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/ja01318a036","article-title":"The determination of enzyme dissociation constants","volume":"56","author":"Lineweaver","year":"1934","journal-title":"J. Am. Chem. Soc."},{"issue":"4617","key":"10.1016\/j.abb.2024.110099_bib68","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/1811199a0","article-title":"Antioxidant determinations by the use of a stable free radical","volume":"181","author":"Blois","year":"1958","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.abb.2024.110099_bib69","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0891-5849(98)00315-3","article-title":"Antioxidant activity applying an improved ABTS radical cation decolorization assay","volume":"26","author":"Re","year":"1999","journal-title":"Free Radical Biol. Med."},{"issue":"2","key":"10.1016\/j.abb.2024.110099_bib70","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/jmbi.1994.1655","article-title":"Drug-protein interactions: refined structures of three sulfonamide drug complexes of human carbonic anhydrase I enzyme","volume":"243","author":"Chakravarty","year":"1994","journal-title":"J. Mol. Biol."},{"issue":"10","key":"10.1016\/j.abb.2024.110099_bib71","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1107\/S1744309109036665","article-title":"High-resolution structure of human carbonic anhydrase II complexed with acetazolamide reveals insights into inhibitor drug design","volume":"65","author":"Sippel","year":"2009","journal-title":"Acta Crystallogr. F"},{"issue":"1","key":"10.1016\/j.abb.2024.110099_bib72","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/s41467-017-01263-3","article-title":"Structure of human lysosomal acid \u03b1-glucosidase\u2013a guide for the treatment of Pompe disease","volume":"8","author":"Roig-Zamboni","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.abb.2024.110099_bib73","series-title":"Schr\u00f6dinger Release 2024-1: Protein Preparation Wizard","year":"2024"},{"key":"10.1016\/j.abb.2024.110099_bib89","doi-asserted-by":"crossref","first-page":"124232","DOI":"10.1016\/j.ijbiomac.2023.124232","article-title":"Discovery of novel benzensulfonamides incorporating 1,2,3,-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors","volume":"239","author":"Buza","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.abb.2024.110099_bib74","series-title":"Schr\u00f6dinger Release 2024-1","year":"2024"},{"issue":"43","key":"10.1016\/j.abb.2024.110099_bib75","doi-asserted-by":"crossref","first-page":"11915","DOI":"10.1002\/slct.202103197","article-title":"Infection medications: assessment in-vitro glutathione S-transferase inhibition and molecular docking study","volume":"6","author":"T\u00fcrke\u015f","year":"2021","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.abb.2024.110099_bib76","series-title":"Schr\u00f6dinger Release 2024-1","year":"2024"},{"key":"10.1016\/j.abb.2024.110099_bib90","doi-asserted-by":"crossref","first-page":"117111","DOI":"10.1016\/j.bmc.2022.117111","article-title":"Exploration of 1,2,3-triazole linked benzensulfonamide derivatives as isoform selective inhibitors of human carbonic anhydrase","volume":"77","author":"Kakakhan","year":"2023","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.abb.2024.110099_bib77","series-title":"Schr\u00f6dinger Release 2024-1: SiteMap","year":"2024"},{"key":"10.1016\/j.abb.2024.110099_bib78","series-title":"Schr\u00f6dinger Release 2024-1: Receptor Grid Generation","year":"2024"},{"key":"10.1016\/j.abb.2024.110099_bib79","series-title":"Schr\u00f6dinger Release 2024-1","year":"2024"},{"issue":"12","key":"10.1016\/j.abb.2024.110099_bib80","doi-asserted-by":"crossref","DOI":"10.1002\/jmr.3063","article-title":"Carbonic anhydrase inhibition by antiviral drugs in vitro and in silico","volume":"36","author":"T\u00fcrke\u015f","year":"2023","journal-title":"J. Mol. Recogn."},{"key":"10.1016\/j.abb.2024.110099_bib81","series-title":"Schr\u00f6dinger Release 2024-1: Glide","year":"2024"},{"key":"10.1016\/j.abb.2024.110099_bib91","doi-asserted-by":"crossref","first-page":"107221","DOI":"10.1016\/j.bioorg.2024.107221","article-title":"Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies","volume":"145","author":"G\u00fcle\u00e7","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.abb.2024.110099_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2024.2331085","article-title":"New N-(1,3,4-thiadiazole-2-yl)acetamide derivatives as human carbonic anhydrase I and II and acetylcholinesterase inhibitors","author":"Dawbaa","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.abb.2024.110099_bib82","series-title":"Schr\u00f6dinger Release 2024-1: Prime","year":"2024"},{"key":"10.1016\/j.abb.2024.110099_bib93","doi-asserted-by":"crossref","first-page":"10979","DOI":"10.1039\/D4NJ01462F","article-title":"Novel asymmetric biscarbothioamides as Alzheimer\u2019s disease associated cholinesterase inhibitors: synthesis, biological activity, and molecular docking studies","volume":"48","author":"Mu\u011flu","year":"2024","journal-title":"New J. Chem."},{"issue":"19","key":"10.1016\/j.abb.2024.110099_bib83","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1080\/07391102.2021.1916599","article-title":"Novel inhibitors with sulfamethazine backbone: synthesis and biological study of multi-target cholinesterases and \u03b1-glucosidase inhibitors","volume":"40","author":"T\u00fcrke\u015f","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"12","key":"10.1016\/j.abb.2024.110099_bib84","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1080\/07391102.2023.2240889","article-title":"Novel beta-lactam substituted benzenesulfonamides: in vitro enzyme inhibition, cytotoxic activity, and in silico interactions","volume":"42","author":"G\u00fcle\u00e7","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.abb.2024.110099_bib85","series-title":"Schr\u00f6dinger Release 2024-1: QikProp","year":"2024"},{"issue":"1","key":"10.1016\/j.abb.2024.110099_bib86","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.abb.2024.110099_bib87","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.abb.2024.110099_bib88","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1021\/ja993663t","article-title":"Prediction of properties from simulations: free energies of solvation in hexadecane, octanol, and water","volume":"122","author":"Duffy","year":"2000","journal-title":"J. Am. Chem. Soc."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986124002212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986124002212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T02:11:44Z","timestamp":1728439904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986124002212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":93,"alternative-id":["S0003986124002212"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2024.110099","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamics of small molecule-enzyme interactions: Novel benzenesulfonamides as multi-target agents endowed with inhibitory effects against some metabolic enzymes","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2024.110099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110099"}}